About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | WEUSKOP6166: Lamotrigine and Aseptic Meningitis

WEUSKOP6166: Lamotrigine and Aseptic Meningitis

NCT01657864·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients must be using lamotrigine for epilepsy or bipolar disorder.
Patients must have at least 180 days history on the database prior to the index of lamotrigine use.
Patients must have medical and pharmacy coverage throughout the study, with no gaps in eligibility.

You may not be if

None

The record

StatusCompleted

PhaseNo phase

Taking part1

StartedMay 2012

UpdatedAug 6, 2012

Conditions